• CCK-8 for Biomaterial Vaccine Safety Testing

  2026-08-27

  Learn how Cell Counting Kit-8 (CCK-8) can support viability, proliferation, and cytotoxicity decisions during biomaterial vaccine development. This article connects WST-8 assay design with transdermal microneedle research while clarifying what metabolic readouts can—and cannot—prove.

• DiR (DiIC 18 (7)) for EV Tracking and Cell Imaging

  2026-08-26

  DiR combines durable membrane labeling with near-infrared readout for live-cell, fixed-tissue, neuronal, and extracellular-vesicle studies. This practical guide shows how to use it to interrogate the Engage & Evasion strategy while avoiding free-dye artifacts, signal misinterpretation, and weak tissue contrast.

• Dextran sulfate sodium salt for DSS Colitis

  2026-08-26

  Build a reproducible intestinal inflammation model with Dextran sulfate sodium salt while separating epithelial injury from true mucosal repair. This workflow connects DSS dosing, barrier readouts, and the GPR35–KLF5 repair circuitry to improve ulcerative colitis research and preclinical decision-making.

• Carfilzomib (PR-171): A Proteostasis Strategy

  2026-08-25

  Carfilzomib (PR-171) offers translational researchers a precise way to interrogate irreversible proteasome inhibition, proteostasis collapse, and stress-linked tumor cell death. This thought-leadership analysis connects its mechanism to the PDI inhibitor–panobinostat findings reported in multiple myeloma and provides a strategic framework for assay design, combination studies, and biomarker development.

• Uridine, Trisodium Salt in RNA Workflows

  2026-08-25

  Uridine, Trisodium Salt supports RNA metabolism studies, cell-based precursor experiments, and vascular biology assays while helping researchers distinguish nucleoside supplementation from direct in vitro transcription substrates. Its high purity and strong aqueous solubility make it a practical reagent for controlled optimization around PRINT RNA delivery workflows.

• Reserpine (N1867): Practical Lab Workflow

  2026-08-24

  Reserpine (SKU N1867) provides a defined, high-purity research reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide addresses identity confirmation, DMSO-based preparation, storage, and QC; the compound is not intended for clinical, diagnostic, therapeutic, or veterinary use.

• SHC-1 Inhibition and CFTR Surface Trafficking

  2026-08-23

  This 2026 study shows that SHC-1-dependent CFTR internalization is detectable across airway and intestinal epithelial models, but pharmacological increases in surface CFTR are restricted to CFBE cells and are not fully selective. The findings refine interpretation of CFTR trafficking assays by separating conserved signaling from cell-specific inhibitor responses.

• ABT-199 as a Mechanistic Apoptosis Probe

  2026-08-22

  ABT-199, also known as Venetoclax, is a highly selective BCL-2 inhibitor for dissecting mitochondrial apoptosis. This article connects its use in hematologic malignancy models with the 2025 discovery of Pol II degradation-dependent apoptotic signaling, offering a sharper framework for apoptosis assay design.

• L-NMMA acetate: Reliable NOS Assay Design

  2026-08-21

  This scenario-driven guide shows how L-NMMA acetate (SKU B6444) can improve interpretation of viability, proliferation, and cytotoxicity experiments by providing defined nitric oxide synthase inhibition. It combines mechanistic evidence from dental follicle cell research with practical guidance on controls, aqueous preparation, storage, and product selection.

• MDL 28170: A Calpain Inhibitor for Assay Design

  2026-08-21

  MDL 28170 is a cell-permeable calpain inhibitor that enables mechanistic studies of protease-driven neuronal injury, synaptic dysfunction, and cell death. This guide translates recent BDNF/TrkB findings into practical assay decisions while defining the compound’s selectivity, cross-model value, and interpretive limits.

• NVP-BGJ398 Phosphate: From Target to Readout

  2026-08-20

  NVP-BGJ398 phosphate is a potent pan-FGFR research inhibitor with applications spanning FGFR-altered cancer models and FGFR3-driven skeletal disease. This article presents a signal-first framework for choosing controls, pathway readouts, and translational assays.

• TPPU Workflows for sEH and Bone Research

  2026-08-20

  TPPU is a nanomolar soluble epoxide hydrolase inhibitor for connecting fatty acid epoxide signaling with inflammatory pain, redox biology, and osteoclast differentiation. This practical guide covers formulation, lipidomic target engagement, cell assays, mouse-study design, and troubleshooting without overstating preclinical evidence.

• Z-WEHD-FMK Workflows for Caspase-1 Research

  2026-08-19

  Z-WEHD-FMK enables rapid pharmacologic dissection of inflammatory caspases in pyroptosis, apoptosis, and pathogen-cell interaction models. This guide connects the compound’s documented Chlamydia application with the HOXC8–caspase-1 mechanism reported in lung cancer, while emphasizing assay controls, formulation, and interpretation limits.

• ONX-0914 (PR-957) Immune Assay Workflows

  2026-08-19

  ONX-0914 (PR-957) provides a practical route to LMP7-focused immunoproteasome inhibition for cytokine assays, PBMC studies, and autoimmune disease models. This guide connects selective pharmacology with extracellular-vesicle proteasome biology while emphasizing controls, handling, and troubleshooting for reproducible results.

• Cimetidine in BBB Transport and Cancer Research

  2026-08-18

  Cimetidine can function as both a histamine-2 receptor antagonist and a mechanism-aware probe in barrier transport experiments. This workflow combines receptor-focused controls with Transwell permeability, recovery analysis, and lysosomal-trapping correction to improve interpretation in BBB and gastrointestinal cancer research.

457 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page